title: Heterogeneity in gamma-glutamyltransferase mRNA expression and glycan structures. Search for tumor-specific variants in human liver metastases and colon carcinoma cells.
abstract: The enzyme gamma-glutamyltransferase (GGT) is frequently overexpressed in cancer cells and tissues and has significant utility as a cancer marker. Significant heterogeneity of the enzyme has been described due to both transcriptional and post-translational variations. For possible use in diagnosis and follow-up of patients with colorectal cancer, a search was performed for specific mRNA subtypes and glycan structures of the enzyme in liver metastases. We found no differences in the distribution of three GGT mRNA subtypes (fetal liver, HepG2, placenta) in metastatic tissue and normal liver tissue. Furthermore, the three subtypes were present in leukocytes isolated from both normal individuals and cancer patients. Two colon carcinoma cell lines (Colo 205 and HCC 2998) also displayed the three forms and no consistent changes in mRNA composition were noted after butyrate-induced differentiation of the cells. Thus, neither of the GGT mRNA subforms appear to be tumor-specific, although some qualitative and quantitative variations were noted. Two distinct glycosylation features were detected for GGT in metastatic tissue in contrast to normal liver GGT; an extreme sialic acid heterogeneity and a significant increase in beta1,6GlcNAc branching. The GGT glycans from the two colon carcinoma cell lines also possessed these features. As butyrate treatment of the cells resulted in an increased sialic acid content and a reduced beta1,6GlcNAc branching, the described carbohydrate structures appear to be part of a tumor-related pattern. We were, however, unable to identify such GGT isoforms in serum from patients with advanced colorectal cancer. This indicates that their usefulness in diagnostic use is doubtful.
authors.affiliation: Department of Medical Biochemistry, Faculty of Medicine, Institute of Medical Biology, University of Tromsö, Norway.
authors.forename: Ingvild
authors.initials: I
authors.lastname: Pettersen
authors.forename: Jeanette Hammer
authors.initials: JH
authors.lastname: Andersen
authors.forename: Kristin
authors.initials: K
authors.lastname: Bjornland
authors.forename: Øystein
authors.initials: Ø
authors.lastname: Mathisen
authors.forename: Roy
authors.initials: R
authors.lastname: Bremnes
authors.forename: Maria
authors.initials: M
authors.lastname: Wellman
authors.forename: Athanase
authors.initials: A
authors.lastname: Visvikis
authors.forename: Nils-Erik
authors.initials: NE
authors.lastname: Huseby
mesh_terms: D002087:Butyrates / Q000378:metabolism; D003110:Colonic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D018740:Genetic Heterogeneity; D006801:Humans; D007962:Leukocytes / Q000378:metabolism; D008113:Liver Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000556:secondary; D011134:Polysaccharides / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D005723:gamma-Glutamyltransferase / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D002087:Butyrates; D011134:Polysaccharides; D012333:RNA, Messenger; D005723:gamma-Glutamyltransferase